drugset / Trial / NCT02872571

Evaluation of the Efficacy of Intramuscular Islet Autograft After Extensive Pancreatectomy

NCT02872571 ↗

Phase 1/2 Active not recruiting 35 enrolled University Hospital, Lille
NaSingle-groupOpen-labelPrevention

Summary

The liver may not be an optimal site for islet transplantation due to obstacles by an instant blood-mediated inflammatory response, and low revascularization of transplanted islets. Therefore, intramuscular islet transplantation offers an attractive alternative, based on its simplicity, enabling easier access for noninvasive graft imaging and cell explantation.

Timeline

Start
2013-03
Primary completion
2026-04
Completion
2026-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Intramuscular Islet Autograft Cell therapy — Intramuscular